miR-1246 promotes osteosarcoma cell migration via NamiRNA-enhancer network dependent on Argonaute 2

Area of Science:

• Molecular Biology
• Cancer Research
• Epigenetics

Background:

• Osteosarcoma metastasis is a major cause of treatment failure.
• Nuclear-activating microRNAs (NamiRNAs) can promote tumor metastasis by targeting enhancers.
• The specific role of NamiRNAs in osteosarcoma metastasis and their mechanisms remain unclear.

Purpose of the Study:

• To investigate the role of NamiRNAs in osteosarcoma metastasis.
• To elucidate the mechanism by which NamiRNAs regulate gene expression and cell migration in osteosarcoma.
• To identify potential therapeutic targets for osteosarcoma metastasis.

Main Methods:

• Extracellular vesicles from malignant osteosarcoma cells (143B) were used to treat benign osteosarcoma cells (MNNG).
• miR-1246 levels and its nuclear localization were assessed.
• Enhancer activity, H3K27ac enrichment, and MMP1 expression were measured.
• Argonaute 2 (AGO2) knockdown and in vitro assays were performed to study AGO2's role.

Main Results:

• Extracellular vesicles from 143B cells significantly increased MNNG cell migration, attributed to elevated miR-1246.
• Nuclear miR-1246 activated migration gene expression (e.g., MMP1) by increasing enhancer activity and H3K27ac enrichment.
• MMP1 expression was inhibited by AGO2 knockdown.
• AGO2 protected miR-1246/enhancer DNA hybrids from degradation, facilitating gene activation.

Conclusions:

• miR-1246 promotes osteosarcoma metastasis by activating gene expression via enhancer interaction, dependent on nuclear AGO2.
• Nuclear AGO2 acts as a protective factor for NamiRNA-mediated gene activation.
• miR-1246 and nuclear AGO2 represent potential therapeutic targets for osteosarcoma metastasis.